← Browse by Condition
Medical Condition

hiv pre exposure prophylaxis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07047716 Phase 3
Recruiting

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

Enrollment
350 pts
Location
United States
Sponsor
Gilead Sciences
View Trial →